Published in J Biol Chem on December 29, 2003
The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet (2005) 2.46
Neutrophil apoptosis: selective regulation by different ligands of integrin alphaMbeta2. J Immunol (2008) 1.56
Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost (2008) 1.30
Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J Neurochem (2008) 1.21
Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am J Respir Cell Mol Biol (2007) 1.20
Plasminogen receptors: the first quarter century. Semin Thromb Hemost (2013) 1.09
Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis. Am J Respir Cell Mol Biol (2012) 1.06
Plasminogen inhibits TNFalpha-induced apoptosis in monocytes. Blood (2006) 1.04
SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair. Arch Dermatol Res (2008) 1.02
Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood (2009) 1.01
SERPINE1 (PAI-1) is a prominent member of the early G0 --> G1 transition "wound repair" transcriptome in p53 mutant human keratinocytes. J Invest Dermatol (2007) 0.97
Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost (2006) 0.94
In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1. Mol Cell Biol (2012) 0.92
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice. Blood (2011) 0.90
Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis. Thromb Haemost (2006) 0.87
Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int (2006) 0.87
Urokinase receptor orchestrates the plasminogen system in airway epithelial cell function. Lung (2013) 0.86
Plasmin on adherent cells: from microvesiculation to apoptosis. Biochem J (2010) 0.82
Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model. Infect Immun (2013) 0.79
Plasmin Activation of Glial Cells through Protease-Activated Receptor 1. Patholog Res Int (2013) 0.78
Accentuating and Opposing Factors Leading to Development of Thoracic Aortic Aneurysms Not Due to Genetic or Inherited Conditions. Front Cardiovasc Med (2015) 0.76
Uptake of Plasmin-PN-1 Complexes in Early Human Atheroma. Front Physiol (2016) 0.75
The basic helix-loop-helix/leucine zipper transcription factor USF2 integrates serum-induced PAI-1 expression and keratinocyte growth. J Cell Biochem (2014) 0.75
The association of SERPINE2 gene with COPD in a Chinese Han population. Yonsei Med J (2011) 0.75
Quantifying the evolutionary dynamics of language. Nature (2007) 6.12
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet (2006) 3.65
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet (2011) 2.86
The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res (2012) 2.08
Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med (2003) 1.95
Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes (2002) 1.79
Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol (2009) 1.74
Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res (2006) 1.71
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc Res (2012) 1.63
Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol (2002) 1.63
Anticoagulant and antithrombotic properties of platelet protease nexin-1. Blood (2009) 1.62
Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology (2005) 1.62
Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein. Blood (2009) 1.61
Radiolabeled fucoidan as a p-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation. J Nucl Med (2011) 1.58
M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc Res (2013) 1.54
(99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. Eur J Nucl Med Mol Imaging (2005) 1.52
Leukocyte activation: the link between inflammation and coagulation during heatstroke. A study of patients during the 2003 heat wave in Paris. Crit Care Med (2008) 1.50
Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation (2004) 1.48
A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin). Thromb Res (2006) 1.44
Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence. Cardiovasc Res (2013) 1.43
Progression of the prothrombotic state in aging Bmal1-deficient mice. Arterioscler Thromb Vasc Biol (2011) 1.43
Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol (2008) 1.41
Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation (2004) 1.33
Collagen is reduced and disrupted in human aneurysms and dissections of ascending aorta. Hum Pathol (2008) 1.30
Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol (2006) 1.29
Elastin haploinsufficiency induces alternative aging processes in the aorta. Rejuvenation Res (2008) 1.26
Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J (2005) 1.26
18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J Nucl Med (2013) 1.26
Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.25
Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol (2007) 1.25
Thrombolytic agents. Thromb Haemost (2005) 1.25
Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. Am J Hum Genet (2011) 1.20
Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study. J Am Coll Cardiol (2005) 1.19
Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol (2007) 1.18
Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol (2006) 1.16
Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A (2005) 1.16
Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica (2012) 1.16
Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS One (2011) 1.14
Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 1.14
Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res (2005) 1.14
Pericellular plasmin induces smooth muscle cell anoikis. FASEB J (2003) 1.12
Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation (2004) 1.12
Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol (2002) 1.12
Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Commun (2005) 1.11
A differential drug screen for compounds that select against antibiotic resistance. PLoS One (2010) 1.09
Regarding "A multilayer stent in the aorta may not seal the aneurysm, thereby leading to rupture". J Vasc Surg (2013) 1.09
B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation (2008) 1.09
Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol (2006) 1.08
HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. FASEB J (2009) 1.08
Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study. Mol Med (2011) 1.07
Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res (2010) 1.07
Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol (2004) 1.07
Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol (2005) 1.06
Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol (2010) 1.05
Cell-derived microparticles: a new challenge in neuroscience. J Neurochem (2009) 1.05
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol (2010) 1.05
A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis. Am J Pathol (2005) 1.04
CD36 promotes adipocyte differentiation and adipogenesis. Biochim Biophys Acta (2012) 1.04
What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res (2006) 1.03
Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochim Biophys Acta (2003) 1.02
MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans. Radiology (2010) 1.02
Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics (2003) 1.01
Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood (2009) 1.01
Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol (2011) 1.01
IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo. Am J Physiol Heart Circ Physiol (2004) 1.01
Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve. Arterioscler Thromb Vasc Biol (2010) 1.01
Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res (2009) 1.01
Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection. J Gene Med (2009) 1.00
Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost (2003) 1.00
The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes. Am J Physiol Heart Circ Physiol (2008) 0.99
Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta. Rejuvenation Res (2008) 0.99
Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardium. Cardiovasc Res (2002) 0.99
Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2011) 0.98
Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia. J Pharmacol Exp Ther (2003) 0.98
Diagnostic and therapeutic strategies for small abdominal aortic aneurysms. Nat Rev Cardiol (2011) 0.97